Factually! with Adam Conover

What Does Ozepmic Actually DO? with Dr. Dhruv Khullar

Apr 3, 2024

Dr. Dhruv Khullar discusses the impact of medications like Ozempic on diabetes, weight loss, heart health, and addiction treatment. They explore societal perceptions of weight, body image, and the challenges in healthcare. The episode also covers the economic influence of Novo Nordisk and concerns with drug manufacturing and compound pharmacies.

54:18

Episode guests

Dhruv Khullar

AI Summary

AI Chapters

Episode notes

Podcast summary created with Snipd AI

Quick takeaways

GLP-1 agonist medications like Ozempic can reduce heart attack and stroke risk.

Obesity requires personalized approaches beyond simple weight loss solutions.

The cost and adherence of GLP-1 agonist drugs raise economic concerns in healthcare systems.

Deep dives

The Potential of GLP-1 Agonist Medications for Weight Loss and Beyond

GLP-1 agonist medications, such as Ozempic, have garnered attention for their weight loss benefits and potential implications beyond obesity and diabetes treatment. Studies suggest these drugs can lead to significant weight loss and reduce the risk of heart attacks and strokes. Additionally, they show promise in addressing addictive behaviors, offering a potentially transformative impact on healthcare. However, the long-term use and cost of these medications raise concerns, and their cosmetic use adds complexity to the conversation.

Introduction

2min

Exploring the Potential of Diabetes Medications for Weight Loss and Addiction Control

6min

Unveiling the Multi-Faceted Impact of a Drug

15min

The Impact of Novo Nordisk in Denmark's Economy and Pharmaceutical Sector

3min

The societal impact of a new weight loss drug

21min

Challenges in Drug Manufacturing and Concerns with Compound Pharmacies

4min

Exploring the Nuances of a Medication's Impact and Concerns

2min

Medication Considerations and Societal Impact

4min

Concluding Remarks and Guest Information

2min

There's been a surge in discourse around medications such as Ozempic, prompting understandable skepticism—Is this another weight loss fad, or the beginning of something new? While it is primarily used to treat diabetes and promote weight loss, there's mounting evidence that shows drugs like Ozempic can reduce the risk of heart attacks and strokes, and potentially be instrumental in treating addiction. In this episode, Adam speaks with Dr. Dhruv Khullar, a physician and assistant professor of health policy and economics at Weill Cornell Medical College, exploring the efficacy, risks, and impact these drugs have on our relationship with weight and food.

SUPPORT THE SHOW ON PATREON: https://www.patreon.com/adamconover

SEE ADAM ON TOUR: https://www.adamconover.net/tourdates/

SUBSCRIBE to and RATE Factually! on:

» Apple Podcasts: https://podcasts.apple.com/us/podcast/factually-with-adam-conover/id1463460577

» Spotify: https://open.spotify.com/show/0fK8WJw4ffMc2NWydBlDyJ

About Headgum: Headgum is an LA & NY-based podcast network creating premium podcasts with the funniest, most engaging voices in comedy to achieve one goal: Making our audience and ourselves laugh. Listen to our shows at https://www.headgum.com.

» SUBSCRIBE to Headgum: https://www.youtube.com/c/HeadGum?sub_confirmation=1

» FOLLOW us on Twitter: http://twitter.com/headgum

» FOLLOW us on Instagram: https://instagram.com/headgum/

» FOLLOW us on TikTok: https://www.tiktok.com/@headgum

» Advertise on Factually! via Gumball.fm

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.